Pathophysiology of Perioperative Temperature Dysregulation

Abstract

Perioperative temperature dysregulation is a common and clinically significant phenomenon encountered in surgical patients, with hypothermia and, less commonly, hyperthermia posing risks for postoperative complications. This review synthesizes current knowledge of the mechanisms underlying perioperative temperature disturbances, explores epidemiology, identifies at-risk populations, delineates clinical features, discusses diagnostic approaches, and evaluates evidence-based management strategies. Recent advances, emerging therapies, and key guideline recommendations are outlined to provide a comprehensive resource for healthcare professionals managing perioperative thermal balance.

Introduction

Maintenance of normothermia during the perioperative period is crucial for optimal surgical outcomes. Core temperature homeostasis is often disrupted by anesthesia, surgical exposure, and environmental factors, leading to perioperative hypothermia or, less frequently, hyperthermia. Such dysregulation adversely affects coagulation, immune function, wound healing, and cardiovascular stability. Understanding the underlying pathophysiology, risk factors, and evidence-based interventions is essential for anesthesiologists, surgeons, and perioperative care teams to mitigate associated morbidity and mortality.

Epidemiology / Disease Burden

Perioperative hypothermia, defined as a core temperature below 36°C, occurs in up to 70% of surgical patients without active warming protocols. The incidence varies with surgical type, duration, patient comorbidities, and intraoperative management. While less prevalent, perioperative hyperthermia, including malignant hyperthermia, can be life-threatening. The burden extends beyond immediate perioperative risks, with increased rates of surgical site infections, transfusion requirements, cardiac events, and prolonged hospital stays. Economic analyses indicate significant healthcare costs attributable to temperature dysregulation, underscoring the need for preventive strategies.

Pathophysiology

Thermoregulation is orchestrated by the hypothalamus, integrating afferent input from central and peripheral thermoreceptors. During anesthesia, particularly with volatile anesthetics and sedative-hypnotics, the hypothalamic set point is impaired, and normal vasoconstrictive and shivering responses are blunted. Redistribution hypothermia is a hallmark of the first hour after induction, as vasodilation shifts core heat to the periphery. Prolonged exposure, fluid administration, and evaporative losses further compound heat loss. Conversely, perioperative hyperthermia may result from excessive warming, infection, or pharmacogenetic disorders such as malignant hyperthermia, which involves uncontrolled skeletal muscle metabolism due to ryanodine receptor mutations.

Risk Factors

Risk factors for perioperative hypothermia include advanced age, low body mass index, major or prolonged surgery, high-volume fluid or blood transfusion, open body cavities, and lack of active warming measures. Pediatric and geriatric populations are particularly vulnerable due to reduced thermogenic capacity and impaired vasomotor responses. Pharmacologic agents such as benzodiazepines, opioids, and neuromuscular blockers further impair thermoregulatory mechanisms. For hyperthermia, susceptibility is heightened in individuals with a family history of malignant hyperthermia, use of triggering anesthetics, or underlying endocrine disorders.

Clinical Features

Perioperative hypothermia presents with mild to severe symptoms: shivering, altered mental status, arrhythmias, coagulopathy, and increased risk of surgical site infection. Intraoperative hypothermia may be masked by anesthetic-induced suppression of shivering. Hyperthermia manifests as unexplained elevation in core temperature, tachycardia, muscle rigidity, metabolic acidosis, and, in the case of malignant hyperthermia, rapid progression to rhabdomyolysis and cardiovascular collapse if not promptly recognized and managed.

Diagnosis

Diagnosis relies on continuous and accurate core temperature monitoring, preferably via esophageal, nasopharyngeal, or bladder probes. Peripheral thermometry is less reliable intraoperatively. For hyperthermia, laboratory evaluation includes arterial blood gases, serum creatine kinase, myoglobin, and electrolyte panels to detect complications of malignant hyperthermia. Diagnostic criteria for perioperative hypothermia are straightforward, while malignant hyperthermia requires prompt clinical recognition and, when available, confirmation with the caffeine-halothane contracture test postoperatively.

Treatment & Management

Active warming is the cornerstone of hypothermia prevention and treatment. Forced-air warming blankets, warmed intravenous fluids, and increasing ambient operating room temperature are effective interventions. Prewarming patients for 30-60 minutes preoperatively can reduce redistribution hypothermia. In cases of hyperthermia, immediate discontinuation of triggering agents, active cooling, administration of dantrolene for malignant hyperthermia, and supportive measures for metabolic derangements are essential. Multimodal protocols tailored to patient risk factors and procedural characteristics yield the best outcomes.

Recent Advances / Emerging Therapies

Recent innovations include precision temperature management systems with feedback-controlled warming and cooling, non-invasive continuous temperature monitors, and pharmacologic modulation of thermoregulatory responses. Novel agents targeting brown adipose tissue thermogenesis and mitochondrial uncoupling are under investigation. Enhanced recovery after surgery (ERAS) protocols now emphasize thermal management as a key element, integrating patient education, preoperative warming, and intraoperative strategies. Ongoing research aims to individualize warming protocols based on genetic and metabolic profiles.

Guideline Recommendations

Major guidelines, including those from the National Institute for Health and Care Excellence (NICE) and the American Society of Anesthesiologists (ASA), recommend maintaining perioperative core temperature above 36°C. They stress prewarming, intraoperative active warming, and vigilant temperature monitoring for all at-risk patients. Early identification and management of hyperthermia, especially malignant hyperthermia, are emphasized, with protocolized responses and availability of dantrolene in operative suites. Adherence to guidelines has been shown to reduce complications and improve patient outcomes.

Conclusion

Perioperative temperature dysregulation remains a significant yet preventable contributor to surgical morbidity and mortality. A thorough understanding of the underlying pathophysiology, risk stratification, and implementation of evidence-based management is essential for optimizing perioperative care. Continued advancements in temperature monitoring and individualized protocols hold promise for further reducing the burden of this complication in surgical patients.